Accession Number: | 0001179110-20-004114 |
Date: | 2020-03-23 |
Issuer: | BLUEPRINT MEDICINES CORP (BPMC) |
Original Submission Date: |
ALBERS JEFFREY W.
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-03-23 | M | 20,000 | a | $1.87 | 141,434 | direct | ||
COMMON STOCK | 2020-03-23 | M | 80 | a | $1.87 | 141,514 | direct | ||
COMMON STOCK | 2020-03-23 | M | 19,920 | a | $8.80 | 161,434 | direct | ||
COMMON STOCK | 2020-03-23 | S | 484 | d | $55.34 | 160,950 | direct | ||
COMMON STOCK | 2020-03-23 | S | 3,293 | d | $54.62 | 157,657 | direct | ||
COMMON STOCK | 2020-03-23 | S | 1,936 | d | $53.54 | 155,721 | direct | ||
COMMON STOCK | 2020-03-23 | S | 2,100 | d | $52.11 | 153,621 | direct | ||
COMMON STOCK | 2020-03-23 | S | 8,850 | d | $51.30 | 144,771 | direct | ||
COMMON STOCK | 2020-03-23 | S | 3,337 | d | $50.40 | 141,434 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.87 | 2020-03-23 | deemed execution date | M | 20,000 (d) | 2024-07-30 | common stock 20,000 | $1.87 | 173,903 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 1.87 | 2020-03-23 | deemed execution date | M | 80 (d) | 2024-07-30 | common stock 80 | $1.87 | 0 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 8.8 | 2020-03-23 | deemed execution date | M | 19,920 (d) | 2025-02-10 | common stock 19,920 | $8.80 | 87,170 | direct |
ID | footnote |
---|---|
f1 | effected pursuant to a trading plan adopted on december 11, 2018 pursuant to rule 10b5-1 under the securities exchange act of 1934, as amended. |
f2 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $55.25 to $55.43 per share. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) to this form 4. |
f3 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $54.15 to $55.04 per share. |
f4 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $53.06 to $53.93 per share. |
f5 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $51.84 to $52.805 per share. |
f6 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $50.84 to $51.82 per share. |
f7 | the price reported is a weighted average price. these shares were sold in multiple transactions at prices ranging from $49.83 to $50.74 per share. |
f8 | this option was granted on july 30, 2014 and is fully vested. |
f9 | this option was granted on february 10, 2015 and is fully vested. |